News & Media

• 2010Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours.
• 2010PH1-derived bivalent bibodies and trivalent tribodies bind differentially to shed and tumour cell-associated MUC1.

Filter by year:

• 2012
• 2011
• 2010
• 2009
• 2008
• 2007
• 2005
• 2004